Rasuvo (methotrexate non-pyrogenic solution for a single subcutaneous injection)

Rasuvo (methotrexate) is a folate analog metabolic inhibitor used to manage severe, active rheumatoid arthritis (RA) (ACR criteria) in adults, or active polyarticular juvenile idiopathic arthritis (pJIA) in children, who have had an insufficient response to, or are intolerant of, nonsteroidal anti-inflammatory drugs (NSAIDs). Rasuvo is also used in adults for symptomatic control of severe, recalcitrant, disabling psoriasis that is not adequately responsive to other forms of therapy.

Otrexup (methotrexate injection)

Otrexup (methotrexate) Injection is a folate analog metabolic inhibitor used in adults to manage severe, active rheumatoid arthritis (RA) (ACR criteria), or children with active polyarticular juvenile idiopathic arthritis (pJIA), who have had an insufficient therapeutic response to, or are intolerant of, an adequate trial of first-line therapy including full dose nonsteroidal anti-inflammatory agents (NSAIDs). Otrexup is also used for the symptomatic control of severe, recalcitrant, disabling psoriasis that is not adequately responsive to other forms of therapy.

Otrexup PFS (methotrexate injection)

Otrexup PFS (methotrexate) is a folate analog metabolic inhibitor indicated for the management of patients with severe, active rheumatoid arthritis (RA) and polyarticular juvenile idiopathic arthritis (pJIA), who are intolerant of or had an inadequate response to first-line therapy; and for symptomatic control of severe, recalcitrant, disabling psoriasis in adults who are not adequately responsive to other forms of therapy. The brand name Otrexup PFS had been discontinued. Generic versions of methotrexate are available.

RediTrex (methotrexate injection)

RediTrex (methotrexate) injection is a folate analog metabolic inhibitor indicated for the management of patients with severe, active rheumatoid arthritis (RA) and polyarticular juvenile idiopathic arthritis (pJIA), who are intolerant of or had an inadequate response to first-line therapy; and for symptomatic control of severe, recalcitrant, disabling psoriasis in adults who are not adequately responsive to other forms of therapy.

Xatmep (methotrexate oral solution)

Xatmep (methotrexate) oral solution is a folate analog metabolic inhibitor indicated for the treatment of pediatric patients with acute lymphoblastic leukemia (ALL) as a component of a combination chemotherapy maintenance regimen; and for management of pediatric patients with active polyarticular juvenile idiopathic arthritis (pJIA) who are intolerant of or had an inadequate response to first-line therapy.

Rheumatrex (methotrexate tablets)

Rheumatrex (methotrexate) is an antimetabolite drug that is used to treat some cancers, severe skin diseases such as severe psoriasis, and to treat forms of rheumatoid arthritis. Rheumatrex is available in generic form.

Uvadex (methoxsalen)

Uvadex (methoxsalen) Sterile Solution is a psoralen photosensitizer used to treat cutaneous T-cell lymphoma (CTCL) and is used in a procedure called photopheresis.

8-MOP (methoxsalen)

Oxsoralen-Ultra (methoxsalen capsules)

Oxoralen-Ultra (methoxsalen) is a naturally occurring substance that is reactive to light (photoactive) used in combination with UVA light therapy to treat severe psoriasis.

Oxsoralen (methoxsalen lotion)

Oxsoralen (methoxsalen lotion) is a topical repigmenting agent used in vitiligo in conjunction with controlled doses of ultraviolet A (320-400 nm) or sunlight.